Literature DB >> 6047824

Platelet stickness in patients with intracranial tumours.

P Millac.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 6047824      PMCID： PMC1748830          DOI： 10.1136/bmj.4.5570.25

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  PLATELET-AGGREGATION BY PHOSPHOLIPIDS AND FREE FATTY ACIDS.

Authors:  J W KERR; I MACAULAY; R PIRRIE; B BRONTE-STEWART
Journal:  Lancet       Date:  1965-06-19       Impact factor: 79.321

2.  Platelet stickiness in multiple sclerosis.

Authors:  E A Caspary; J Prineas; H Miller; E J Field
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

3.  Platelet adhesiveness in multiple sclerosis.

Authors:  H P Wright; R H Thompson; K J Zilkha
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

4.  Platelet stickiness in multiple sclerosis.

Authors:  J H Millar; J D Merrett; A M Dalby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-06       Impact factor: 10.154
  4 in total
  5 in total

1.  Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.

Authors:  H Ian Robins; M Won; Wendy F Seiferheld; Christopher J Schultz; Ali K Choucair; David G Brachman; William F Demas; Minesh P Mehta
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

2.  Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

Authors:  R Sawaya; P Glas-Greenwalt
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

3.  Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.

Authors:  H Ian Robins; Anne O'Neill; Mark Gilbert; Mark Olsen; Ronald Sapiente; Brian Berkey; Minesh Mehta
Journal:  Cancer Chemother Pharmacol       Date:  2007-09-20       Impact factor: 3.333

Review 4.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.

Authors:  Bo H Chao; Lisa Lepeak; Ticiana Leal; H Ian Robins
Journal:  Thrombosis       Date:  2011-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.